Why the study?
Does hormone replacement therapy prevent adverse cardiac events in postmenopausal women?
Does hormone replacement therapy prevent adverse cardiac events in postmenopausal women?
The cardioprotective benefits of HRT in postmenopausal women remain inconclusive, highlighting the need to rely on proven options for cardiovascular disease prevention.
PURPOSE: To examine the effect of hormone replacement therapy (HRT) on adverse cardiac events in postmenopausal women. DATA SOURCES: A systematic review of all available scientific literature (513 articles) on the cardioprotective benefits of HRT, including research reports, meta-analyses, and commentaries. CONCLUSIONS: Epidemiological studies have consistently suggested that HRT administered to postmenopausal women significantly lowers the risks of cardiovascular events. However, the claimed benefits might have been exaggerated. The results of the only large randomized clinical trial did not show similar benefits as those reported from observational studies. Research findings about cardiovascular protection of HRT remain inconclusive. IMPLICATIONS FOR PRACTICE: While waiting for more definitive data, it is appropriate to consider other options that have been proven safe and effective in the prevention of cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Schumann et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: